Analysis of study drug-related interstitial lung disease (ILD) in patients (pts) with HER2+ metastatic breast cancer (mBC) treated with trastuzumab deruxtecan (T-DXd) Meeting Abstract


Authors: Powell, C. A.; Modi, S.; Iwata, H.; Takahashi, S.; Nie, K.; Qin, A.; Singh, J.; Taitt, C.; Verma, S.; Camidge, D. R.
Abstract Title: Analysis of study drug-related interstitial lung disease (ILD) in patients (pts) with HER2+ metastatic breast cancer (mBC) treated with trastuzumab deruxtecan (T-DXd)
Meeting Title: ESMO Breast Cancer Virtual Congress 2021
Journal Title: Annals of Oncology
Volume: 32
Issue: Suppl. 2
Meeting Dates: 2021 May 5-8
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2021-05-01
Start Page: S61
End Page: S62
Language: English
ACCESSION: WOS:000648924400096
DOI: 10.1016/j.annonc.2021.03.106
PROVIDER: wos
Notes: Meeting Abstract: 92O -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Shanu Modi
    264 Modi